MainHealthMental HealthDisorders › Clomipramine ( Anafranil ) and Depersonalization Disorder

Clomipramine ( Anafranil ) and Depersonalization Disorder

Edit Page
Report
Scan day: 13 February 2014 UTC
16
Virus safety - good
Description: Combined clomipramine ( Anafranil ) and SSRIs in the treatment of adolescent depersonalization.
Clomipramine ( Anafranil ) and Depersonalization Disorder Simeon D, Stein DJ, Hollander E Mount Sinai School of Medicine, ACKGROUND: Although there is a dire paucity of data on the pharmacologic treatment of depersonalization disorder, there have been a few reports in the literature suggesting that selective serotonin reuptake inhibitors may be of therapeutic benefit. In this study, we undertook to evaluate the efficacy of the potent serotonin reuptake inhibitor clomipramine in treating depersonalization. METHODS: Eight subjects with DSM-III-R depersonalization disorder were entered into a double-blind crossover trial consisting of 8 weeks desipramine and 8 weeks clomipramine. Due to the very small size of the trial findings are presented descriptively. RESULTS: Of 7 subjects who entered the clomipramine trial, two showed significant improvement in depersonalization. Three subjects dropped out early, unable to tolerate adverse effects. Of 6 subjects who entered the desipramine trial, I showed significant improvement in depersonalization. One clomipramine responder was subsequently followed in open maintenance treatment with clomipramine for 4 years, and her depersonalization symptoms remained in almost complete remission, with relapses upon each attempt to taper off or switch medication. CONCLUSIONS: Clomipramine may be a promising pharmacologic treatment for primary depersonalization disorder and warrants further investigation.
Size: 1452 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Clomipramine ( Anafranil ) and Depersonalization Disorder
Keywords:
Description:combined clomipramine ( Anafranil ) and SSRIs in the treatment of adolescent OCD.
IP-address:195.82.124.125

WHOIS Info

NS
Name Server: NS1.BLTC.NET
Name Server: NS2.BLTC.NET
WHOIS
Status: clientDeleteProhibited
Status: clientRenewProhibited
Status: clientTransferProhibited
Status: clientUpdateProhibited
Date
Creation Date: 01-oct-1997
Expiration Date: 30-sep-2015